Analysis of protease activity using quantum dots and resonance energy transfer

Theranostics

Volumn 2, Issue 2, 2012, Pages 127-138

  Kim, Gae Baik ^a   Kim, Young Pil ^a  

^a Hanyang University   (South Korea)

Author keywords

BRET; Energy transfer; FRET; Luciferase; Multiplex; Nanoparticle; Protease; Quantum dot; Quenche

Indexed keywords

LUCIFERASE; NANOPARTICLE; PROTEINASE; PROTEINASE INHIBITOR; QUANTUM DOT;

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; ENERGY TRANSFER; ENZYME ACTIVITY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HIGH THROUGHPUT SEQUENCING; HUMAN; NANOMEDICINE; NONHUMAN; PROTEIN DEGRADATION; REVIEW; SENSITIVITY ANALYSIS;

EID: 84864418602     PISSN: None     EISSN: 18387640     Source Type: Journal    
DOI: 10.7150/thno.3476     Document Type: Review

References (84)

1. Puente XS, Sanchez LM, Overall CM, Lopez-Otin C. Human and mouse proteases: a comparative genomic approach. Nat Rev Genet. 2003; 4: 544-58.
2. Overall CM, Tam EM, Kappelhoff R, Connor A, Ewart T, Morrison CJ, et al. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors. Biol Chem. 2004; 385: 493-504.
3. Neurath H. The versatility of proteolytic enzymes. J Cell Biochem. 1986; 32: 35-49.
4. Lopez-Otin C, Overall CM. Protease degradomics: a new chal-lenge for proteomics. Nat Rev Mol Cell Biol. 2002; 3: 509-19.
5. Turk B. Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov. 2006; 5: 785-99.
6. Mason SD, Joyce JA. Proteolytic networks in cancer. Trends Cell Biol. 2011; 21: 228-37.
7. Overall CM, Kleifeld O. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy. Nat Rev Cancer. 2006; 6: 227-39.
8. Concha NO, Abdel-Meguid SS. Controlling apoptosis by inhibition of caspases. Curr Med Chem. 2002; 9: 713-26.
9. Schwienhorst A. Direct thrombin inhibitors - a survey of recent developments. Cell Mol Life Sci. 2006; 63: 2773-91.
10. White CM. Thrombin-directed inhibitors: pharmacology and clinical use. Am Heart J. 2005; 149: S54-60.
11. Laack E, Kohler A, Kugler C, Dierlamm T, Knuffmann C, Vohwinkel G, et al. Pretreatment serum levels of matrix metalloproteinase-9 and vascular endothelial growth factor in non-small-cell lung cancer. Ann Oncol. 2002; 13: 1550-7.
12. Ohuchi E, Azumano I, Yoshida S, Iwata K, Okada Y. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (matrilysin) using monoclonal antibodies. Clin Chim Acta. 1996; 244: 181-98.
13. Srinivasan R, Huang X, Ng SL, Yao SQ. Activity-based fingerprinting of proteases. Chembiochem. 2006; 7: 32-6.
14. Sun H, Chattopadhaya S, Wang J, Yao SQ. Recent developments in microarray-based enzyme assays: from functional annotation to substrate/inhibitor fingerprinting. Anal Bioanal Chem. 2006; 386: 416-26.
15. Bjurlin MA, Bloomer S, Nelson CJ. Characterization of proteolytic activity of protease. Biotechnol Lett. 2002; 24: 191-5.
16. Zhao Z, Raftery MJ, Niu XM, Daja MM, Russell PJ. Application of in-gel protease assay in a biological sample: characterization and identification of urokinase-type plasminogen activator (uPA) in secreted proteins from a prostate cancer cell line PC-3. Electrophoresis. 2004; 25: 1142-8.
17. Schilling O, Overall CM. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat Biotechnol. 2008; 26: 685-94.
18. Thomas DA, Francis P, Smith C, Ratcliffe S, Ede NJ, Kay C, et al. A broad-spectrum fluorescence-based peptide library for the rapid identification of protease substrates. Proteomics. 2006; 6: 2112-20.
19. Nagai T, Miyawaki A. A high-throughput method for development of FRET-based indicators for proteolysis. Biochem Bioph Res Co. 2004; 319: 72-7.
20. Mahajan NP, Harrison-Shostak DC, Michaux J, Herman B. Novel mutant green fluorescent protein protease substrates reveal the activation of specific caspases during apoptosis. Chem Biol. 1999; 6: 401-9.
21. Hawrylak P, Narvaez GA, Bayer M, Forchel A. Excitonic absorption in a quantum Dot. Phys Rev Lett. 2000; 85: 389-92.
22. Moreels I, Hens Z. On the interpretation of colloidal quantum-dot absorption spectra. Small. 2008; 4: 1866-8.
23. Gao X, Cui Y, Levenson RM, Chung LW, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol. 2004; 22: 969-76.
24. Chan WCW, Maxwell DJ, Gao XH, Bailey RE, Han MY, Nie SM. Luminescent quantum dots for multiplexed biological detection and imaging. Curr Opin Biotech. 2002; 13: 40-6.
25. Wu XY, Liu HJ, Liu JQ, Haley KN, Treadway JA, Larson JP, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol. 2002; 21: 41-6.
26. Jaiswal JK, Mattoussi H, Mauro JM, Simon SM. Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nat Biotechnol. 2003; 21: 47-51.
27. Bruchez M, Jr., Moronne M, Gin P, Weiss S, Alivisatos AP. Semiconductor nanocrystals as fluorescent biological labels. Science. 1998; 281: 2013-6.
28. Hines MA, Guyot-Sionnest P. Synthesis and characterization of strongly luminescing ZnS-Capped CdSe nanocrystals. J Phys Chem. 1996; 100: 468-71.
29. Yu JS, Liu YF. Selective synthesis of CdTe and high luminescence CdTe/CdS quantum dots: The effect of ligands. J Colloid Interf Sci. 2009; 333: 690-8.
30. Michalet X, Pinaud F, Lacoste TD, Dahan M, Bruchez MP, Alivisatos AP, et al. Properties of fluorescent semiconductor nanocrystals and their application to biological labeling. Single Mol. 2001; 2: 261-76.
31. Lounis B, Bechtel HA, Gerion D, Alivisatos P, Moerner WE. Photon antibunching in single CdSe/ZnS quantum dot fluorescence. Chem Phys Lett. 2000; 329: 399-404.
32. Tran PT, Goldman ER, Anderson GP, Mauro JM, Mattoussi H. Use of luminescent CdSe-ZnS nanocrystal bioconjugates in quantum dot-based nanosensors. Phys Status Solidi B. 2002; 229: 427-32.
33. Willard DM, Van Orden A. Quantum dots - Resonant energy-transfer sensor. Nat Mater. 2003; 2: 575-6.
34. Clapp AR, Medintz IL, Mauro JM, Fisher BR, Bawendi MG, Mattoussi H. Fluorescence resonance energy transfer between quantum dot donors and dye-labeled protein acceptors. J Am Chem Soc. 2004; 126: 301-10.
35. Zhang CY, Yeh HC, Kuroki MT, Wang TH. Single-quantum-dot-based DNA nanosensor. Nat Mater. 2005; 4: 826-31.
36. Mauro JM, Medintz IL, Clapp AR, Mattoussi H, Goldman ER, Fisher B. Self-assembled nanoscale biosensors based on quantum dot FRET donors. Nat Mater. 2003; 2: 630-8.
37. Oh E, Hong MY, Lee D, Nam SH, Yoon HC, Kim HS. Inhibition assay of biomolecules based on fluorescence resonance energy transfer (FRET) between quantum dots and gold nanoparticles. J Am Chem Soc. 2005; 127: 3270-1.
38. Oh E, Lee D, Kim YP, Cha SY, Oh DB, Kang HA, et al. Nanoparticle-based energy transfer for rapid and simple detection of protein glycosylation. Angew Chem Int Ed. 2006; 45: 7959-63.
39. Wargnier R, Baranov AV, Maslov VG, Stsiapura V, Artemyev M, Pluot M, et al. Energy transfer in aqueous solutions of oppositely charged CdSe/ZnS core/shell quantum dots and in quantum dot-nanogold assemblies. Nano Lett. 2004; 4: 451-7.
40. Kim YP, Oh YH, Oh E, Ko S, Han MK, Kim HS. Energy transfer-based multiplexed assay of proteases by using gold nanoparticle and quantum dot conjugates on a surface. Anal Chem. 2008; 80: 4634-41.
41. Wang SP, Mamedova N, Kotov NA, Chen W, Studer J. Antigen/antibody immunocomplex from CdTe nanoparticle bioconjugates. Nano Lett. 2002; 2: 817-22.
42. So MK, Xu C, Loening AM, Gambhir SS, Rao J. Self-illuminating quantum dot conjugates for in vivo imaging. Nat Biotechnol. 2006; 24: 339-43.
43. Rao JH, So MK, Loening AM, Gambhir SS. Creating self-illuminating quantum dot conjugates. Nat Protoc. 2006; 1: 1160-4.
44. Chaniotakis N, Frasco MF. Bioconjugated quantum dots as fluorescent probes for bioanalytical applications. Anal Bioanal Chem. 2010; 396: 229-40.
45. Biju V, Mundayoor S, Omkumar RV, Anas A, Ishikawa M. Bioconjugated quantum dots for cancer research: Present status, prospects and remaining issues. Biotechnol Adv. 2010; 28: 199-213.
46. Krull UJ, Algar WR, Tavares AJ. Beyond labels: A review of the application of quantum dots as integrated components of assays, bioprobes, and biosensors utilizing optical transduction. Anal Chim Acta. 2010; 673: 1-25.
47. Rao JH, Xia ZY. Biosensing and imaging based on bioluminescence resonance energy transfer. Curr Opin Biotech. 2009; 20: 37-44.
48. Mattoussi H, Sapsford KE, Pons T, Medintz IL. Biosensing with luminescent semiconductor quantum dots. Sensors-Basel. 2006; 6: 925-53.
49. Rogach AL, Klar TA, Lupton JM, Meijerink A, Feldmann J. Energy transfer with semiconductor nanocrystals. J Mater Chem. 2009; 19: 1208-21.
50. Rogach AL. Fluorescence energy transfer in hybrid structures of semiconductor nanocrystals. Nano Today. 2011; 6: 355-65.
51. Mattoussi H, Clapp AR, Medintz IL. Forster resonance energy transfer investigations using quantum-dot fluorophores. Chemphyschem. 2006; 7: 47-57.
52. Medintz IL, Sapsford KE, Berti L. Materials for fluorescence resonance energy transfer analysis: Beyond traditional donor-acceptor combinations. Angew Chem Int Ed. 2006; 45: 4562-88.
53. Rotello VM, Agasti SS, Rana S, Park MH, Kim CK, You CC. Nanoparticles for detection and diagnosis. Adv Drug Deliver Rev. 2010; 62: 316-28.
54. Krull UJ, Algar WR. New opportunities in multiplexed optical bioanalyses using quantum dots and donor-acceptor interactions. Anal Bioanal Chem. 2010; 398: 2439-49.
55. Mattoussi H, Medintz IL. Quantum dot-based resonance energy transfer and its growing application in biology. Phys Chem Chem Phys. 2009; 11: 17-45.
56. Chaniotakis N, Frasco MF. Semiconductor Quantum Dots in Chemical Sensors and Biosensors. Sensors. 2009; 9: 7266-86.
57. Weissleder R, Tung CH, Mahmood U, Bogdanov A. In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol. 1999; 17: 375-8.
58. Kim K, Lee S, Ryu JH, Park K, Lee A, Lee SY, et al. Polymeric Nanoparticle-Based Activatable Near-Infrared Nanosensor for Protease Determination In Vivo. Nano Lett. 2009; 9: 4412-6.
59. Kircher MF, Weissleder R, Josephson L. A dual fluorochrome probe for imaging proteases. Bioconjugate Chem. 2004; 15: 242-8.
60. Stockholm D, Bartoli M, Sillon G, Bourg N, Davoust J, Richard I. Imaging calpain protease activity by multiphoton FRET in living mice. J Mol Biol. 2005; 346: 215-22.
61. Medintz IL, Clapp AR, Brunel FM, Tiefenbrunn T, Uyeda HT, Chang EL, et al. Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates. Nat Mater. 2006; 5: 581-9.
62. Shi L, De Paoli V, Rosenzweig N, Rosenzweig Z. Synthesis and application of quantum dots FRET-based protease sensors. J Am Chem Soc. 2006; 128: 10378-9.
63. Chang E, Miller JS, Sun J, Yu WW, Colvin VL, Drezek R, et al. Protease-activated quantum dot probes. Biochem Bioph Res Co. 2005; 334: 1317-21.
64. Rosenzweig Z, Shi LF, Rosenzweig N. Luminescent quantum dots fluorescence resonance energy transfer-based probes for enzymatic activity and enzyme inhibitors. Anal Chem. 2007; 79: 208-14.
65. Medintz IL, Prasuhn DE, Feltz A, Blanco-Canosa JB, Susumu K, Stewart MH, et al. Quantum Dot Peptide Biosensors for Monitoring Caspase 3 Proteolysis and Calcium Ions. Acs Nano. 2010; 4: 5487-97.
66. Clapp AR, Goldman ER, Uyeda HT, Chang EL, Whitley JL, Medintz IL. Monitoring of Enzymatic Proteolysis Using Self-Assembled Quantum Dot-Protein Substrate Sensors. J Sensors. 2008; 2008: 1-10.
67. Chen W, Biswas P, Cella LN, Kang SH, Mulchandani A, Yates MV. A quantum-dot based protein module for in vivo monitoring of protease activity through fluorescence resonance energy transfer. Chem Commun. 2011; 47: 5259-61.
68. Kim HS, Kim YP, Oh YH, Oh E. Chip-based protease assay using fluorescence resonance energy transfer between quantum dots and fluorophores. Biochip J. 2007; 1: 228-33.
69. Medintz IL, Boeneman K, Mei BC, Dennis AM, Bao G, Deschamps JR, et al. Sensing Caspase 3 Activity with Quantum Dot-Fluorescent Protein Assemblies. J Am Chem Soc. 2009; 131: 3828-9.
70. Yun CS, Javier A, Jennings T, Fisher M, Hira S, Peterson S, et al. Nanometal surface energy transfer in optical rulers, breaking the FRET barrier. J Am Chem Soc. 2005; 127: 3115-9.
71. Jennings TL, Singh MP, Strouse GF. Fluorescent lifetime quenching near d = 1.5 nm gold nanoparticles: probing NSET validity. J Am Chem Soc. 2006; 128: 5462-7.
72. Jennings TL, Schlatterer JC, Singh MP, Greenbaum NL, Strouse GF. NSET molecular beacon analysis of hammerhead RNA substrate binding and catalysis. Nano Lett. 2006; 6: 1318-24.
73. Dulkeith E, Morteani AC, Niedereichholz T, Klar TA, Feldmann J, Levi SA, et al. Fluorescence quenching of dye molecules near gold nanoparticles: radiative and nonradiative effects. Phys Rev Lett. 2002; 89: 203002.
74. Pons T, Medintz IL, Sapsford KE, Higashiya S, Grimes AF, English DS, et al. On the quenching of semiconductor quantum dot photoluminescence by proximal gold nanoparticles. Nano Lett. 2007; 7: 3157-64.
75. Nabiev I, Sukhanova A, Devy M, Venteo L, Kaplan H, Artemyev M, et al. Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells. Anal Biochem. 2004; 324: 60-7.
76. Lein M, Nowak L, Jung K, Koenig F, Lichtinghagen R, Schnorr D, et al. Analytical aspects regarding the measurement of metalloproteinases and their inhibitors in blood. Clin Biochem. 1997; 30: 491-6.
77. Nikkola J, Vihinen P, Vuoristo MS, Kellokumpu-Lehtinen P, Kahari VM, Pyrhonen S. High serum levels of matrix metalloproteinase-9 and matrix metalloproteinase-1 are associated with rapid progression in patients with metastatic melanoma. Clin Cancer Res. 2005; 11: 5158-66.
78. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002; 295: 2387-92.
79. Denis LJ, Verweij J. Matrix metalloproteinase inhibitors: present achievements and future prospects. Invest New Drugs. 1997; 15: 175-85.
80. Hidalgo M, Eckhardt SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 2001; 93: 178-93.
81. Loening AM, Fenn TD, Wu AM, Gambhir SS. Consensus guided mutagenesis of Renilla luciferase yields enhanced stability and light output. Protein Eng Des Sel. 2006; 19: 391-400.
82. Rao JH, Xia ZY, Xing Y, So MK, Koh AL, Sinclair R. Multiplex Detection of Protease Activity with Quantum Dot Nanosensors Prepared by Intein-Mediated Specific Bioconjugation. Anal Chem. 2008; 80: 8649-55.
83. Tong AK, Li Z, Jones GS, Russo JJ, Ju J. Combinatorial fluorescence energy transfer tags for multiplex biological assays. Nat Biotechnol. 2001; 19: 756-9.
84. Suzuki M, Husimi Y, Komatsu H, Suzuki K, Douglas KT. Quantum dot FRET Biosensors that respond to pH, to proteolytic or nucleolytic cleavage, to DNA synthesis, or to a multiplexing combination. J Am Chem Soc. 2008; 130: 5720-5.